Clinical Trial Detail

NCT ID NCT01849276
Title Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Northwestern University
Indications

chronic lymphocytic leukemia

acute myeloid leukemia

Therapies

Cytarabine + Metformin

Age Groups: adult

No variant requirements are available.